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The vestibular evoked myogenic potential (VEMP) test is a 
relatively new diagnostic tool that is in the process of being 
investigated in patients with specific vestibular disorders. 
Briefly, the VEMP is a biphasic response elicited by loud 
clicks or tone bursts recorded from the tonically contracted 
sternocleidomastoid muscle, being the only resource available 
to assess the function of the saccule and the lower portion of 
the vestibular nerve. Aim: In this review, we shall highlight 
the history, methods, current VEMP status, and discuss 
its specific application in the diagnosis of the Ménière’s 
Syndrome. 
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INTRODUCTION
Vestibular evoked myogenic potentials (VEMP) are 
inhibitory electrical potentials generated after a sound sti-
mulus (clicks or pure tones), originated in the saccule and 
conducted by the lower portion of the vestibular nerve all 
the way to the central nervous system (CNS), generating 
inhibitory electrical responses picked up by electrodes pla-
ced on the sternocleidomastoid muscle (SCM)1,2. In English, 
these potentials are known by the acronym VEMP, mea-
ning Vestibular Evoked Myogenic Potentials. The reason 
why we have had a growing interest on this topic in recent 
years is because of the physiological origin (saccule and 
lower division of the vestibular nerve) of these potentials 
and their possible clinical applications.
Under the evolutionary viewpoint, the cochlea 
was the last portion to develop within the membranous 
labyrinth3-5, which suggests that in some species of fish 
and even in some mammals, the saccule also has an au-
ditory function, causing some authors to speculate about 
the existence of some sensorial cells to sound stimulus 
in the saccule of human beings4,6,7. Still considering this 
evolutionary characteristic, it is believed that when we are 
submitted to a high intensity sound stimulus, these remai-
ning saccule cells are stimulated, triggering an inhibitory 
reflex to the ipsilateral SCM muscle, causing its relaxation 
with consequent contraction of the contralateral muscle.
It is exactly this unilateral inhibitory reflex which 
we capture with electrodes positioned on the SCM muscle 
that we know as VEMP. These are exactly the remaining 
hair cells in the saccule that would originate VEMP, and 
this stimulus is taken to the CNS through the lower por-
tion of the vestibular nerve (IVN)2,7-10. This makes VEMP a 
new method that neurotologists have at hand to diagnose 
and investigate the vestibular system, because until then 
there was no exclusive way to assess saccule and IVN 
function.
OBJECTIVE
The goal of the present review is to highlight the 
history, modus operandi, current status of the research 
involving VEMPs, and also to discuss its specific applica-
tions in the diagnosis of Ménière’s syndrome, vestibular 
schwannoma, superior semicircular canal dehiscence syn-
drome, perilympathic fistula, vestibular neuritis and other 
vestibular lesions, in an attempt to help otolaryngologists 
and neurologists work with this new diagnostic tool.
MÉTHOD
Based on a broad literature review - the authors 
used the MEDLINE database (www.pubmed.com), and 
on the clinical experience acquired in a reference tertiary 
hospital for neurotology disorders in the USA, they carried 




The first sound evoked vestibular responses were 
described by Von Békésy in 1935. He used high intensity 
sound stimuli (about 134 dB) in order to generate head 
movements towards the sound stimulus7. The explana-
tion for this phenomenon was the proximity between the 
stapes footplate and the saccule macula hair cells, which 
would activate the afferent neurons. This proximity be-
tween the stapes footplate and the saccule macula has 
been broadly described in the international literature, by 
means of macro and microscopic anatomical studies of 
the temporal bone11.
In 1964 we had the first reports on short-latency 
myogenic electrical evoked potentials12,13; however, it was 
only 7 years later that Towsend et al. noticed that the true 
origin of these potentials was the saccule14. The authors 
proved it when they found VEMPs present in deaf patients; 
however, they were absent in patients submitted to ves-
tibular neurectomy. Later, these same authors discovered 
that VEMP responses were present in patients who had 
been submitted to ablation of the semicircular canals by 
streptomycin and in patients, who had benign paroxysmal 
postural vertigo (BPPV), while these same potentials were 
absent in patients with Ménière’s syndrome14.
In order to reinforce the physiological basis of 
VEMPs, McCue & Guinan identified some fibers from the 
inferior division of the vestibular nerve in cats, which 
responded electrically to sound stimuli above 80 dB SPL 
(sound pressure level), which increased their electrical 
activity as the stimulus intensified15,16, confirming the hy-
pothesis that these muscle inhibitory electrical potentials 
were originated in the saccule and, consequently, had 
their afferent pathways in the IVN.
Since then, the interest for this topic has been 
on the rise, with a significant increase in the number of 
publications in recent years about VEMPs1,7,17-23. It was 
only in 2005 that more than 30 papers were published in 
English2, and in 2006 this number went up to 33 (source 
www.pubmed.com). It is believed that in 2007, this number 
will be even greater (Figure 1).
 
VEMP test performance
These potentials are generated after high intensity 
sound stimuli (clicks or pure tones), of 0.1 msec of du-
ration, at about 140 to 145 dB SPL (about 90 dB hearing 
level), sounded in an ear phone (monaural or bilateral). 
The patients are put in a chair, seated and instructed to 
turn their heads to the opposite side of the sound stimulus, 
in order to contract the contralateral SCM muscle. VEMPs 
are read by electrodes placed on the patient’s SCM (ip-
silateral to the sound stimulus), the positive electrode is 
placed on the upper third of the muscle, while the negative 
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electrode is placed on the muscle tendon, just above the 
clavicle (Figure 2A).
This electrode placement can happen in an inver-
se way, causing response wave inversion. The ground 
electrode is usually positioned on the patient’s vertex. 
Although the SCM muscle is the most frequently site used 
to obtain vestibular responses, some authors attained these 
responses from other muscles such as the trapezius and 
muscles in the legs and arms3,24.
It is worth to bear in mind that one needs a normal 
middle ear in order to be able to record VEMPs, since 
small air-bone gaps of 8.75 dB are enough to dampen the 
responses25. The electrical responses from these potentials 
are made up of two biphasic waves, the first is positive, 
with a latency around 13ms, known as p13; followed by 
another wave, this time negative, with a latency around 
23ms, known as n23 (Figure 2B).
These responses are present in most of the normal 
individuals studied5, differently from a second biphasic 
complex known as n34-p44, which according to Colebatch 
would be absent in 40% of the normal individuals studied26, 
while Robertson described that this second complex would 
be present in 68% of normal individuals27. Because of the 
lack of reproducibility of this second complex (n34-p44), 
the vast majority of these studies with VEMP only considers 
the first biphasic complex (p13-n23)1,2,7-10,17,26,28.
One of the most controversial points regarding 
VEMPs is the relationship observed between the electrical 
response amplitudes and the level of contraction of the 
muscles tested (usually the SCM). This relationship was 
noticed by Colebatch et al., in 1994 and confirmed by many 
other studies1,2,5,7-9,26. This relationship is relevant because 
we would need standardized muscle contractions among 
the patients, and if it does not happen, it becomes very 
hard to be able to compare the test of an elderly patient 
with that from a young athlete, who very likely has a much 
higher level of muscle contraction. Thus, many studies 
are currently used to monitor SCM contraction, such as 
electromyography and biofeedback5,7,23.
Another controversial point regarding VEMPs is that 
the sound stimulus is generated through clicks or tone 
bursts. Many authors study this topic9,10,29. In 2003, Cheng 
et al. did a study in which they compared the influence 
of clicks and tone bursts in the generation of vestibular 
responses. They concluded that VEMPs generated by clicks 
have a greater response index in normal individuals, grea-
ter amplitude of waves p13-n23 and lower latency9,29. These 
data show that when the physician is reading a VEMP test, 
he/she must know which was the sound stimulus used, 
since it impacts directly on wave amplitude and latency. 
Nonetheless, in 2004 Rauch et al. showed that within the 
range of frequencies tested to generate VEMP responses, 
500 Hz was the most sensitive. Moreover, he introduced a 
new way of analyzing VEMP results, by studying not only 
amplitude and latency, but also the response threshold in 
four different frequencies (250, 500, 750 and 1000Hz)30. 
(Figure 2C)
So far, there are no specific devices to be used in 
VEMP testing, and most of the Centers use the ABR equi-
pment (audiometric analysis of the auditory nerve and 
brainstem) to record these responses. Some authors also 
use other means to trigger these potentials in patients with 
conductive hearing loss, they use a bone stimulus by gently 
tapping the skull of the patients with a small hammer31. 
They attained responses in 10ms (positive wave) and 17ms 
(negative wave) in patients in whom the sound stimulus 
was incapable of generating such responses because of 
their conductive hearing loss.
Figure 1. Annual publications on the Vestibular Evoked Myogenic 
Potential (VEMP) since 1995. Notice that as of the year 2000, there was 
a quick increase in the number of publications dealing with VEMP use. 
Source: www.pubmed.com.
Figure 2a. VEMP test on the left side with earbud phones and elec-
trodes placed on the SCM. The patients are placed on a comfortable 
chair and are instructed to turn their heads to the direction contrary to 
that of the sound stimulus, so as to have SCM muscle contraction to 
the ipsilateral side of the sound stimulus.
Figure 2b. VEMP typical wave in a normal patient. Showing the first 
positive wave (P1) around 13ms and the second negative wave (N1) 
around 23ms.
Figure 2c. Typical VEMP curve in a normal patient, showing the res-
ponse threshold of the main frequencies tested.
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Clinical applicability
Differently from what happens in the auditory 
system, the vestibular system is much more complex and 
much less known and studied, that is why the interest on 
VEMPs has grown in recent years, because these poten-
tials reflect the function of the otolithic organs (saccule) 
and the IVN, something that so far was not possible to be 
evaluated by the numerous other vestibular tests, such as 
vector-electronystagmography, the rotating chair test and 
the platform test2.
The caloric test which, without any doubt is the 
most used test to check vestibular function, is limited to 
the workings of the lateral semicircular canal and the upper 
portion of the vestibular nerve in each side separately, 
while the platform test does not assess each one of the 
labyrinths separately, nor one of the systems in charge 
of body balance (vision, labyrinth and proprioception), 
separately.
Many publications have shown VEMPs used as a 
means to diagnose or even to help diagnose the most di-
verse neurotological diseases, such as Ménière’s disease, 
superior semicircular canal dehiscence, vestibular neuro-
nitis, vestibular schwannomas, control after intratympanic 
administration of gentamicin and even perilymphatic 
fistulas1,2,5,7,19,28,30,32,33. The role of VEMPs in each one of 
these situations is described as follows:
 
Vestibular Neuronitis
It is one of the most frequent causes of vertigo and 
it is normally diagnosed based on the patient’s clinical 
history, associated with a caloric test that shows a unila-
teral functional deficit. 34 According to previously held 
studies, we know that both branches of the vestibular 
nerve (inferior and superior) can be affected by this dise-
ase; however, based on studies by Goebel et al. in 2001, 
we can have some explanations about the possible reason 
why the upper portion is much more frequently affected 
than its inferior counterpart35.
It is exactly based on this differentiation between the 
upper and lower branches that VEMPs can be utilized. In 
1995, Halmagyi et al. studied 22 patients with diagnosis of 
vestibular neuronitis and did not get caloric responses in 
the affected sides of these patients. Curiously, he observed 
that when submitted to VEMP testing, the responses were 
normal in 6 patients, reduced in 5 and absent in 1133. 
This proves that some patients have both portions of the 
vestibular nerve involved, while others have lesions in its 
upper portion only. Such fact is very important regarding 
the prognosis of these patients, since the patients with 
absent or altered VEMPs will hardly develop BPPV in the 
posterior semicircular canal, since the nerve that innerva-
tes this canal is damaged (IVN). Now, those patients with 
manifestations of vestibular neuronitis and normal VEMPs 
show that upper division of the nerve was involved, it is 
possible that patient will develop posterior canal BPPV 
in the future36.
 
Superior Semicircular Canal Dehiscence
In 2001, researchers from the Johns Hopkins Uni-
versity in the United States, headed by Professor Lloyd 
B. Minor, described a vestibular entity not previously re-
ported in the literature, called superior semicircular canal 
dehiscence37. This syndrome is characterized by vertigo 
and nystagmus triggered by sound and/or pressure stimuli, 
and its pathophysiology is based on the “Third Window” 
theory. The existence of this third window in the internal 
ear (besides the round and oval windows) would cause 
an impedance reduction in the inner ear, allowing a better 
membranous labyrinth fluid movement and consequently 
a greater deflection of the vestibular sensors to sound and 
pressure stimuli37-40.
Based on this physiopathological explanation, 
VEMPs have become rather important, since the existen-
ce of this third vibratory window would cause a greater 
movement of the stapes on the oval window, and con-
sequently a greater stimulation on the saccule macula 
to the sound stimuli employed. This would bring down 
VEMP thresholds in almost all the frequencies tested, and 
such data has been confirmed by numerous studies, such 
as the one carried out by Brantberg et al. in 1999, which 
tested VEMPs in 3 patients with superior semicircular canal 
dehiscence, noticing a threshold reduction in the affected 
side of all patients, especially within the range between 
500 Hz to 1000 Hz41.
A similar study was carried out by this same group 
in 2001, when 8 patients with superior semicircular canal 
dehiscence syndrome were submitted to VEMP testing and 
all had threshold reduction in the affected side; 4 of the 
8 patients tested had normal audiometry and 6 of the 8 
had normal responses in the caloric test42. These studies 
reinforce the importance of VEMPs in the diagnosis of this 
syndrome that often times has a varied clinical manifesta-
tion, normal audiometric findings or findings that mimic 
otosclerosis (conductive hearing loss) and that can only be 
confirmed by means of a high resolution CT-scan37-39,42.
 
Vestibular Schwannoma
This benign tumor which affects the vestibular 
pathways is always a diagnostic hypothesis considered in 
the most varied clinical cases. Currently, the most efficient 
method to diagnose it, and also the most expensive one is 
Magnetic Resonance Imaging (MRI). Nonetheless, because 
of its high cost and the impossibility of performing the test 
in all suspected patients, the ABR also plays an important 
role in the diagnosis of vestibular schwannomas5.
Knowing that VEMP neural pathways involve the 
inferior portion of the vestibular nerve, this diagnostic 
method can also be used to help in the diagnosis of vesti-
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bular schwannomas. Some studies in the literature already 
show this important contribution of VEMPs, such as the 
one developed by Murofushi et al. in 1998, who obser-
ved 80% of altered VEMPs in 17 patients with established 
diagnosis of vestibular schwannoma43. In 2001, Takeichi 
et al. performed a similar study in which he observed alte-
red VEMPs in 13 of 18 patients diagnosed with vestibular 
schwannoma confirmed by MRI44.
In a general way, VEMPs can contribute to the 
diagnosis of vestibular tumors, but must not be used as 
the sole diagnostic method, because it only assesses the 
function of the inferior vestibular nerve. Nonetheless, 
when performed together with MRI, the ABR, audiometry 
and caloric test, they may help in the exact location of the 
tumor in the vestibular pathways.
 
Ménière’s Syndrome (MS)
Among all the clinical applications of VEMPs, this 
can be the one with the greatest clinical relevance. Besides 
prior studies in temporal bones, the relationship between 
the endolymphatic hydrops and MS is well established45-50. 
Schuknecht et al. showed that the most frequently involved 
sites by endolymphatic hydrops are the cochlea, followed 
by the saccule and the utriculus, respectively11,46,47,49,51. Since 
the saccule is considered the site of origin of VEMPs, it 
is expected to find VEMPs altered even in early stages of 
the Ménière’s Syndrome.
In 2004, Rauch et al. published a study in which 
they showed VEMPs present in about 94% of the patients 
with MS in the affected side and the frequency thresholds 
between 250 Hz and 2,000 Hz were increased30. Nonethe-
less, one of the most interesting pieces of data of this study 
was the fact that about 27% of the asymptomatic ears from 
these patients with unilateral MS had alterations in this test. 
When we compared this result to data from temporal bone 
studies that found about 38% of endolymphatic hydrops 
in asymptomatic ears of patients with MS1 and epidemio-
logical studies that reported bilateral involvement of MS 
in 30% to 35% of the patients, we concluded that VEMPs 
may be a diagnostic method for endolymphatic hydrops 
in initial stages, and it can serve as a prognostic factor for 
bilateral involvement in MS.
Many other studies were also published in the 
international literature recently about VEMPs in patients 
with MS. In 2001, Murofushi et al. reported that 51% of the 
patients with MS had no response to the VEMP test52, while 
Waele et al., doing the same study, observed an index 
of 54% of response absence in the VEMP test in patients 
with MS53. Other authors, performed studies comparing 
the relationship between the glycerol test and VEMPs, 
concluding that VEMP results after administering glycerol 
were altered, and VEMP testing is the only useful method 
to diagnose endolymphatic hydrops54,55.
 
Perilymphatic Fissure
In 2006, Modugno et al. from the University of 
Bologna, Italy, published a study in which VEMP testing 
was used for the diagnosis of endolymphatic fistula ca-
ses56. They reported four cases in which VEMP response 
thresholds were reduced with stimuli in the frequency 
of 500Hz. The possible explanation for this threshold 
lowering is based on the same theory that explains this 
phenomenon in cases of superior semicircular canal dehis-
cence, a third vibratory window in the internal ear would 
reduce the impedance, consequently causing a reduction 
in these thresholds. One important criticism to this study 
published in 2006 is the small number of patients tested 
and the absence of a longer follow up.
 
Monitoring after treatment with intratympanic gentami-
cin
In recent years, the Ménière’s disease treatment in 
cases resistant to clinical treatment started to be carried 
out through the administration of intratympanic gentami-
cin, in an attempt to reduce vertigo symptoms in these 
patients57. After this therapy, many professionals performed 
an electronystagmography with caloric test in an attempt 
to confirm if the gentamicin dose employed was enough 
to cause damage to the vestibular cells and it is exactly 
with this aim that VEMPs can also be used.
In 2002, De Waele et al., showed that 92% of the 
patients submitted to intratympanic injection of gentamicin 
had no responses in VEMP testing in one month and they 
kept like that for even one year after treatment58.
FINAL REMARKS
VEMP testing is a new complementary test, which 
may contribute, together with other neurologic tests, for 
the diagnosis of many and diverse vestibular disorders, 
among them we stress: Ménière’s Syndrome and Superior 
Semicircular Canal Dehiscence.
The test is currently used in tertiary reference centers 
that deal with neurotological disorders. Nonetheless, the 
authors stress that since this is a new diagnostic method, 
the use of VEMPs is still not totally adapted to clinical 
use, since most of the facilities still don’t have their own 
equipment (using the same ABR equipment), trained pro-
fessionals for their proper realization and interpretation, 
and lack international standardization to analyze results.
Another extremely important point to be highlighted 
is the need for standardization in relation to monitoring 
SCM muscle contraction level, before VEMPs are employed 
in clinical use, since VEMP responses are broadly depen-
dent on the level of activities of this muscle.
At any rate, VEMP testing seems to be a promising 
complementary test, especially for providing information 
on the function of the saccule and inferior portion of the 
vestibular nerve.
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